Clinical & Diagnostic
Acer Expands SpatialLabs Pro With NVIDIA Omniverse, Vision Engineering, and Smart Surgery Integrations
Integration with NVIDIA Omniverse libraries via OpenXR runtime supports enhanced spatial awareness for industrial designs and simulations Partnership wi...
September 04, 2025 | News
South Korea’s AMI Pharm Reports Phase 2 Success of ‘AYP-101,’ a Potential New Leader in Nonsurgical Fat Reduction
AMI Pharm's 'AYP-101' Sets to Become a New Leader in Nonsurgical Fat Reduction with Phase 2 Trial Success 'AYP-101,' a Promising Nonsurgical Solution, H...
September 02, 2025 | News
Genentech and Alnylam Advance Zilebesiran into Phase III Outcomes Trial for Hypertension
Phase III trial informed by comprehensive KARDIA data set generated through three Phase II studies: KARDIA-1, KARDIA-2 and KARDIA-3 – – ...
September 02, 2025 | News
Alphamab Oncology Reports Strong H1 2025 Growth and Pipeline Advancements, Achieving Profitability
Alphamab Oncology (stock code: 9966.HK) reported interim financial results for the six months ended June 30, 2025 and highlighted recent business...
September 01, 2025 | Company results
ACROBiosystems and South Korea’s DAAN Biotherapeutics Sign Strategic MOU to Advance Precision Immuno-Oncology
ACROBiosystems, a global biotechnology company dedicated to accelerating the drug development process through innovative tools and solutions, announced tha...
August 29, 2025 | News
Basecare Medical Secures NMPA Approval For VitBase Culture Medium Marking Breakthrough In China’s Assisted Reproductive Field
Suzhou Basecare Medical Co., Ltd. achieved a major breakthrough—its globally leading Gems culture medium (embryo handling solution VitBase) has offic...
August 27, 2025 | Regulatory
iNtRON Bio Files Patents for Groundbreaking IMPA™ Gene-Editing Technology Targeting Pasteurella Bacteriophages
Development of gene-editing technology for Pasteurella bacteriophages using the IMPA™ platform Establishment of an advanced platform tec...
August 27, 2025 | News
Akeso Reports Positive Phase 3 Results For Gumokimab In Ankylosing Spondylitis And Manfidokimab In Atopic Dermatitis
Akeso Inc. announced positive results from its Phase 3 clinical trial of gumokimab (AK111), a novel, fully human anti-IL-17A monoclonal antibod...
August 26, 2025 | News
Spain’s Ministry of Health Approves Access To Novocure’s TTFields Therapy For Newly Diagnosed Glioblastoma Patients
Eligible patients can receive TTFields therapy through the Spanish National Health System Novocure announced that Spain’s Ministry of Heal...
August 26, 2025 | News
Transforming Cancer Care in Japan and Asia-Pacific: Thermo Fisher’s Jane Li on Accelerating Precision Oncology with Next-Gen Diagnostics
BioPharma APAC spoke with Jane Li, Senior Director, Pharma CDx and CRO Partnership at Thermo Fisher Scientific, about the development of the Oncomine&trade...
August 25, 2025 | Expert Insight
SMSbiotech Launches First-in-Human Trial of Small Mobile Stem Cells for COPD in Australia
SMSbiotech, a San Diego–based leader in regenerative medicine, announced the initiation of its first-in-human Phase 1 clinical trial for C...
August 22, 2025 | News
BioDlink Secures Indonesian Approval for Bevacizumab, Accelerating ASEAN and Global Expansion
BioDlink announced that its Bevacizumab Injection has obtained marketing authorization from Indonesia's National Agency of Drug and Food Con...
August 22, 2025 | News
RemeGen and Santen Form Strategic Alliance on RC28-E for Asia and Greater China
RemeGen Co., a leading Chinese biopharmaceutical company, announced that it has entered into an agreement with Santen Pharmaceutical (China) Co., Ltd. ("Sa...
August 20, 2025 | News
Sanofi and AstraZeneca’s Beyfortus Receives HSA Approval to Prevent RSV in Infants
Beyfortus (nirsevimab) is the only option that can offer RSV protection designed for all infants with proven high, sustained efficacy, favourable safety ...
August 20, 2025 | Regulatory
Most Read
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
